Evidence map›Paper›PMID 31544310›Full record

ArticleEMBO reports2019

STK38 kinase acts as XPO1 gatekeeper regulating the nuclear export of autophagy proteins and other cargoes.

Alexandre Pj Martin, Maarten Jacquemyn, Joanna Lipecka, Cerina Chhuon, Vasily N Aushev, Brigitte Meunier, Manish K Singh, Nicolas Carpi, Matthieu Piel, Patrice Codogno and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in EMBO reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. The NDR family of kinases: essential regulators of aging.Frontiers in molecular neuroscience · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Karyopherin-mediated nucleocytoplasmic transport.Nature reviews. Molecular cell biology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 4 countries.

Alexandre Pj MartinART Group, Inserm U830, Paris, France.ORCID 0000-0003-3875-6754
Maarten JacquemynLaboratory of Virology and Chemotherapy, KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
Joanna LipeckaInserm U894, Center of Psychiatry and Neuroscience, Paris, France.
Cerina ChhuonUniversité Paris Descartes, Sorbonne Paris Cité, Paris, France.
Vasily N AushevIcahn School of Medicine at Mount Sinai, New York, NY, USA.
Brigitte MeunierART Group, Inserm U830, Paris, France.
Manish K SinghART Group, Inserm U830, Paris, France.
Nicolas CarpiInstitut Curie, Centre de Recherche, Paris Sciences et Lettres Research University, Paris, France.
Matthieu PielInstitut Curie, Centre de Recherche, Paris Sciences et Lettres Research University, Paris, France.
Patrice CodognoUniversité Paris Descartes, Sorbonne Paris Cité, Paris, France.
Alexander HergovichCancer Institute, University College London, London, UK.
Maria Carla ParriniART Group, Inserm U830, Paris, France.
Gerard ZalcmanART Group, Inserm U830, Paris, France.
Ida Chiara GuerreraUniversité Paris Descartes, Sorbonne Paris Cité, Paris, France.
Dirk DaelemansLaboratory of Virology and Chemotherapy, KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
Jacques H CamonisART Group, Inserm U830, Paris, France.ORCID 0000-0003-2047-4150
Inserm · FRDélégation Paris 5 · FRCentre National de la Recherche Scientifique · FRRega Institute for Medical Research · BEIcahn School of Medicine at Mount Sinai · USUniversity College London · GB

Funding

Association Christelle BouillotAssociation pour la Recherche sur le Cancer 29928Fonds Wetenschappelijk OnderzoekInstitut CurieInstitut National de la Santé et de la Recherche Médicale (Inserm) PC201530Ligue Contre le Cancer 24098Université de Recherche Paris Sciences et Lettres (PSL)
6 · The paper itself

Abstract

STK38 (also known as NDR1) is a Hippo pathway serine/threonine protein kinase with multifarious functions in normal and cancer cells. Using a context-dependent proximity-labeling assay, we identify more than 250 partners of STK38 and find that STK38 modulates its partnership depending on the cellular context by increasing its association with cytoplasmic proteins upon nutrient starvation-induced autophagy and with nuclear ones during ECM detachment. We show that STK38 shuttles between the nucleus and the cytoplasm and that its nuclear exit depends on both XPO1 (aka exportin-1, CRM1) and STK38 kinase activity. We further uncover that STK38 modulates XPO1 export activity by phosphorylating XPO1 on serine 1055, thus regulating its own nuclear exit. We expand our model to other cellular contexts by discovering that XPO1 phosphorylation by STK38 regulates also the nuclear exit of Beclin1 and YAP1, key regulator of autophagy and transcriptional effector, respectively. Collectively, our results reveal STK38 as an activator of XPO1, behaving as a gatekeeper of nuclear export. These observations establish a novel mechanism of XPO1-dependent cargo export regulation by phosphorylation of XPO1's C-terminal auto-inhibitory domain.

Indexed as

AutophagyCarrier ProteinsCell NucleusChromatography, LiquidComputational BiologyExportin 1 ProteinHippo Signaling PathwayHumansKaryopherinsPhosphorylationProtein BindingProtein Interaction MappingProtein Serine-Threonine KinasesProtein TransportReceptors, Cytoplasmic and NuclearSignal TransductionCarrier ProteinsExportin 1 ProteinKaryopherinsProtein Serine-Threonine KinasesReceptors, Cytoplasmic and NuclearSTK38 protein, humanAPEX2autophagySTK38XPO1YAP1

Identifiers

PMID31544310
PMCPMC6832005
OpenAlexW2973547900

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.